Reuters logo
BRIEF-Benitec in-licenses clinical program for head and neck cancer from NantWorks
December 23, 2016 / 11:20 AM / a year ago

BRIEF-Benitec in-licenses clinical program for head and neck cancer from NantWorks

Dec 23 (Reuters) - Benitec Biopharma Ltd

* Benitec Biopharma Ltd - Agreement to develop a clinical stage asset to treat head and Neck Squamous Cell Carcinoma

* Benitec Biopharma Ltd - Has executed an exclusive, world-wide sublicensing agreement that will enable Benitec, in collaboration with NantWorks

* Benitec Biopharma - Will work with NantWorks to finalize terms of its scientific collaboration with a targeted date for execution of 27 January, 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below